Treatment-aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction.

in IEEE transactions on medical imaging by Qinghui Liu, Elies Fuster-Garcia, Ivar Thokle Hovden, Bradley J MacIntosh, Edvard O S Grodem, Petter Brandal, Carles Lopez-Mateu, Donatas Sederevicius, Karoline Skogen, Till Schellhorn, Atle Bjornerud, Kyrre Eeg Emblem

TLDR

  • The study presents a novel model for predicting future tumor growth and multi-parametric MRI of diffuse gliomas under different treatment plans, combining diffusion probabilistic models and deep-segmentation neural networks.
  • The model demonstrates high-performance segmentation and uncertainty estimation capabilities, offering potential for clinical decision-making and personalized medicine approaches.
  • The study highlights the importance of incorporating sequential multi-parametric MRI and treatment information for improved modeling accuracy and generalizability.

Abstract

Diffuse gliomas are malignant brain tumors that grow widespread through the brain. The complex interactions between neoplastic cells and normal tissue, as well as the treatment-induced changes often encountered, make glioma tumor growth modeling challenging. In this paper, we present a novel end-to-end network capable of future predictions of tumor masks and multi-parametric magnetic resonance images (MRI) of how the tumor will look at any future time points for different treatment plans. Our approach is based on cutting-edge diffusion probabilistic models and deep-segmentation neural networks. We included sequential multi-parametric MRI and treatment information as conditioning inputs to guide the generative diffusion process as well as a joint segmentation process. This allows for tumor growth estimates and realistic MRI generation at any given treatment and time point. We trained the model using real-world postoperative longitudinal MRI data with glioma tumor growth trajectories represented as tumor segmentation maps over time. The model demonstrates promising performance across various tasks, including generating high-quality multi-parametric MRI with tumor masks, performing time-series tumor segmentations, and providing uncertainty estimates. Combined with the treatment-aware generated MRI, the tumor growth predictions with uncertainty estimates can provide useful information for clinical decision-making.

Overview

  • The study presents a novel end-to-end network for predicting future tumor masks and multi-parametric MRI of diffuse gliomas under different treatment plans.
  • The approach combines cutting-edge diffusion probabilistic models and deep-segmentation neural networks, incorporating sequential multi-parametric MRI and treatment information as conditioning inputs.
  • The model is trained using real-world postoperative longitudinal MRI data with glioma tumor growth trajectories, aiming to provide tumor growth estimates and realistic MRI generation at any given treatment and time point.

Comparative Analysis & Findings

  • The model demonstrates promising performance across various tasks, including generating high-quality multi-parametric MRI with tumor masks, performing time-series tumor segmentations, and providing uncertainty estimates.
  • The study shows the potential for the proposed model to provide useful information for clinical decision-making, combining treatment-aware generated MRI with uncertainty estimates to guide treatment planning.
  • The results highlight the challenges and limitations of glioma tumor growth modeling, emphasizing the importance of incorporating sequential multi-parametric MRI and treatment information to improve modeling accuracy.

Implications and Future Directions

  • The study's findings have significant implications for the development of personalized and precision medicine approaches for glioma treatment, enabling estimation of tumor growth trajectories and uncertainty estimates for more informed treatment planning.
  • Future research directions include investigating the model's generalizability across different patient populations, tumor subtypes, and treatment modalities.
  • The potential for integrating this model with other imaging modalities, such as positron emission tomography (PET) and functional magnetic resonance imaging (fMRI), could further enhance its predictive capabilities and clinical applicability.